Elan Corp is a neuroscience-based biotechnology company headquartered in Ireland. Co.'s business is organized into two business units: BioNeurology and Elan Drug Technologies (EDT). Co.'s BioNeurology business unit engages in research, development and commercial activities primarily in the areas of Alzheimer's disease, Parkinson's disease, MS, Crohn's disease and severe chronic pain. Co. has a range of products at various stages of development in relation to each of these therapeutic areas. EDT develops and manufactures pharmaceutical products that deliver clinical benefits to patients, using its proprietary drug technologies in collaboration with pharmaceutical companies.
|
Free ELN Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Hold (2.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |